RCKT as of Oct 31 · 14:52 ET
RCKTNasdaqPharmaceutical Preparations

Rocket Pharmaceuticals, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±22.4%
avg realized
±3.4%
Nov 7 '24±26.3%▲+1.16%×0.04
Feb 27 '25±22.3%▲+0.53%×0.02
May 8 '25±16.5%▼−0.71%×0.04
Aug 7 '25±16.7%▼−7.44%×0.45
Q3 FY25±24.5%▼−1.86%×0.08
Q1 FY26±17.9%▲+10.60%×0.59
May 7 '26±25.4%▼−1.09%×0.04
Q2 FY26±29.1%▼−3.85%×0.13
quarterimplied−30%0+30%realized×
Q2 FY26±29.1%▼−3.85%×0.13
May '26±25.4%▼−1.09%×0.04
Q1 FY26±17.9%▲+10.60%×0.59
Q3 FY25±24.5%▼−1.86%×0.08
Aug '25±16.7%▼−7.44%×0.45
May '25±16.5%▼−0.71%×0.04
2 older reports
Feb '25±22.3%▲+0.53%×0.02
Nov '24±26.3%▲+1.16%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

5disclosed supplier and customer ties in SEC filingsSEC filings
3tracked funds holding RCKTN-PORT · Aug 31 '26

Bear2

8 of 8recent reports where the move came in under the options-implied rangeEarnings history
4 of 25of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

RCKT report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±39.4% into Nov 5 earnings (Oct 22 close).Source
Oct 68-KMaterial agreement: Loan and Security Agreement with Hercules Capital, Inc.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.